Co Diagnostics
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Utah, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2401 S Foothill Dr Ste D, Salt Lake City...Phone Number
(801) 438-1036Website
www.co-dx.comRevenue
<$5 MillionStock Symbol
CODXIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Co Diagnostics
Co-Diagnostics, Inc. is a molecular diagnostics company focused on the development, commercialization, and advancement of innovative diagnostic technologies designed to improve access to accurate, reliable, and affordable testing solutions. The company operates within the healthcare and life sciences sectors, specializing in molecular diagnostic products that support disease detection, clinical decision-making, research applications, and public health initiatives.Explore more
Co Diagnostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Co Diagnostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Co Diagnostics launches new products
Website visits: Recent activity has been detected on your website
Click to see if Co Diagnostics had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Co Diagnostics has new funding data
Co Diagnostics, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Co Diagnostics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Co Diagnostics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Co Diagnostics
Check out if Co Diagnostics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Co Diagnostics as Masked Content
Find 3 more new buyers
Company Profile Activity
Activity Insights
Co Diagnostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Co Diagnostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Co Diagnostics.
Co Diagnostics financials insights
Gather financial insights about Co Diagnostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Debt
$750K
2017
Stock Offering
$7.1M
2023
Grant
$2.3M
2026
Stock/Share Issuance
$3M
Co Diagnostics Tech Stack
A closer look at the technologies used by Co Diagnostics
See more technologies
Most Recent Scoops
New Hire
Executive Move
Executive Moves, New Hire
Person-Based
Product Development, Medical Research, Accessibility, Healthcare Technology
Funding
Funding
Earnings
Earnings, Finance
Earnings
Earnings, Finance
Co Diagnostics News & Media
Co-Diagnostics Reports Second Quarter 2026 Financial Results
Advancing Commercialization Through FDA Submission, Global Clinical Progress and Manufacturing Expansion Strengthening Integrated Co-Dx PCR Platform Through Scientific Innovation, Cloud Connectivity and AI-Enabled Capabilities SALT LAKE CITY, Aug. 13, 2026 /PRNewswire/ -- Co-Diagnostics,...Co-Diagnostics Submits FDA 510(k) Premarket Notification for Upper Respiratory Point-of-Care Test
Submission includes a concurrent CLIA Waiver by Application for use of the test on the Co-Dx PCR Pro® instrument in decentralized point-of-care settings SALT LAKE CITY, Aug. 6, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics...Co-Diagnostics Joint Venture CoSara Provides Ebola Test Kits for Analytical Studies
Company also completes proof of concept for the first blood-borne test for Ebola on Co-Dx PCR Pro ® instrument SALT LAKE CITY, July 28, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for...Co-Diagnostics Joint Venture CoSara Initiates Clinical Studies in India for Tuberculosis Test on PCR Platform
PCR Pro Instruments and MTB Test Kits Now Deployed to Select Labs Across India SALT LAKE CITY, July 22, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the development of molecular...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Co Diagnostics
Sign Up For FreeTo access detailed company insights
Co-Diagnostics, Inc. is a molecular diagnostics company focused on the development, commercialization, and advancement of innovative diagnostic technologies designed to improve access to accurate, reliable, and affordable testing solutions. The company operates within the healthcare and life sciences sectors, specializing in molecular diagnostic pr... Read More
